Insider Trades of ROBERTSON SANFORD Information

Click on the column header to resort 'ascending (^) or descending (v).

Individual Insider Trades

Company Relation Last Date Type Tran OwnerType Shares Traded Last Price Shares Held
SALESFORCE COM INC Director 05/24/2011 Form 4 Acquisition (Non Open Market) direct 1,500 0 6,000
SALESFORCE COM INC Director 08/23/2011 Form 4 Acquisition (Non Open Market) direct 800 0 6,800
SALESFORCE COM INC Director 11/22/2011 Form 4 Acquisition (Non Open Market) direct 800 0 7,600
RPX CORP Director 11/10/2011 Form 4 Buy direct 28,676 14.03 99,148
RPX CORP Director 11/11/2011 Form 4 Buy direct 21,324 14.33 120,472
DOLBY LABORATORIES, INC. Director 02/07/2012 Form 4 Acquisition (Non Open Market) direct 7,900 0 24,538
SALESFORCE COM INC Director 02/28/2012 Form 4 Acquisition (Non Open Market) direct 800 0 8,400
SALESFORCE COM INC Director 05/22/2012 Form 4 Acquisition (Non Open Market) direct 800 0 9,200
SALESFORCE COM INC Director 08/28/2012 Form 4 Acquisition (Non Open Market) direct 800 0 10,000
SALESFORCE COM INC Director 09/13/2012 Form 4 Sell direct 10,000 154.1794
SALESFORCE COM INC Director 11/27/2012 Form 4 Acquisition (Non Open Market) direct 800 0 800
SALESFORCE COM INC Director 12/05/2012 Form 4 Sell direct 800 155.9013
SALESFORCE COM INC Director 12/14/2012 Form 4 Sell direct 17,767 166.9192
SALESFORCE COM INC Director 12/17/2012 Form 4 Sell direct 22,233 166.7541
DOLBY LABORATORIES, INC. Director 02/05/2013 Form 4 Acquisition (Non Open Market) direct 9,310 0 33,848
SALESFORCE COM INC Director 02/26/2013 Form 4 Acquisition (Non Open Market) direct 800 0 800
RPX CORP Director 02/27/2013 Form 4 Buy direct 50,000 12.8348 170,472

Latest News Headlines

Blackstone, Prologis Acquire Industrial Portfolio    9:25PM ET  - Dow Jones Business News

Ford to Close Australia Plants on Costs    9:24PM ET  - Dow Jones Business News

Traders Sue Options Markets Over Fees    8:54PM ET  - Dow Jones Business News

AEA Investors Hires Banks for CPG International Sale: Sources -Reuters    8:07PM ET  - Dow Jones Business News

FDA Recommends Running Phase 2b Trial of Proellex(R)-V in the Treatment of Severe Menstrual Bleedin    8:01PM ET  - GlobeNewswire

View All
Create your free portfolio